NL-OMON52756招募中不适用
A prospective, explorative cohort study to assess the value of an ex vivo radiosensitivity assay as a BIOmarker of treatment Response in Oropharyngeal Cancer (BIO-ROC). - The BIO-ROC study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Clinical diagnosis of squamous cell carcinoma of the oropharynx, with or
- •without histological confirmation
- •- In case of already histology-confirmed oropharyngeal cancer - primary tumor
- •accessible for re-sampling without general anaesthesia
- •- Eligible for curative treatment with radiotherapy with or without the
- •addition of systemic agents
- •- Written informed consent obtained
- •- Age >= 18 years
排除标准
- •- Patients with histology-confirmed oropharyngeal cancer, only accessible for
- •re-sampling only under general anaesthesia
- •- Patients currently under treatment for other malignant disease (unless basal
- •cell carcinoma of the skin)
- •- Previous radiotherapy in the head and neck area (with overlapping RT area)
- •- Recurrent oropharyngeal cancer
研究者
相似试验
招募中
不适用
A prospective, descriptive cohort study evaluating the prevalence and incidence of exocrine pancreatic insufficiency in patients with pancreatic cancer.NL-OMON35011Academisch Medisch Centrum50
尚未招募
不适用
A prospective, explorative cohort study to identify biomarkers of treatment response in oropharyngeal cancer.Oropharyngeal cancerNL-OMON27421Erasmus MC200
招募中
Unknown
An observational, prospective cohort study to evaluate the long-term safety and efficacy of infliximab SC in patients with Ankylosing spondylitis, Rheumatoid arthritis in KoreaDiseases of the musculoskeletal system and connective tissueKCT0009223Chonnam National University Bitgoeul Hospital1,412
招募中
Unknown
An observational, prospective cohort study to evaluate the long-term safety and efficacy of infliximab SC in patients with Crohn's disease, Ulcerative colitis in KoreaKCT0009009Chung-Ang Univerisity Hospital1,500
进行中（未招募）
1 期
An exploratory, observational cohort study investigating commercially available treatments which may reduce the scab stage of recurrent herpes labialisEUCTR2005-001384-60-GBGlaxoSmithKline Consumer Healthcare36